NCCN Guidelines® Insights - Prostate Cancer Early Detection, Version 1.2014
The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for Prostate Cancer Early Detection
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Prostate Cancer Early Detection
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician